Phase II CONDOR Trial suggests tolerance of inhibitor durvalumab in patients with metastatic head cancer Read more
Quidel seeks 510 (k) Clearance for QuickVue Influenza A+B Test complying FDA’s Class II RIDT Requirements Read more
MOLOGEN forays into global co-development agreement with ONCOLOGIE for lead compound lefitolimod Read more